Atli, AbdullahSelvi, YavuzYildiz, AydinKaya, Mehmet Cemal2024-04-242024-04-2420131017-7833https://doi.org/10.5455/bcp.20130303114826https://hdl.handle.net/11468/20109Diplopia is a condition that involves seeing double and impairs quality of life. Acute diplopia can be seen with some general medical drugs and psychotropic drugs. Aripiprazole is a new atypical antipsychotic agent; it has partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors. This paper reports development of diplopia, a rare adverse effect of psychotropic drugs, in a 24 year old patient with schizophreniform disorder following use of oral aripiprazole. Clinicians should keep in mind that diplopia may occur with aripiprazole treatment.eninfo:eu-repo/semantics/openAccessAripiprazoleDiplopiaAdverse EffectArticle234353356WOS:0003399830000092-s2.0-8489179079810.5455/bcp.20130303114826N/AQ4